CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Sale | −600 | $277.91 | $167K | 12,400 |
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Sale | −400 | $279.10 | $112K | 12,000 |
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Sale | −1,800 | $280.66 | $505K | 10,200 |
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Sale | −2,656 | $281.97 | $749K | 7,544 |
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Sale | −2,628 | $282.97 | $744K | 4,916 |
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Sale | −1,549 | $283.85 | $440K | 3,367 |
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Sale | −829 | $285.15 | $236K | 2,538 |
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Sale | −2,038 | $285.74 | $582K | 500 |
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Sale | −400 | $286.62 | $115K | 100 |
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Sale | −100 | $287.86 | $29K | 0 |
| 2023-01-03 | Lynch Brian Joseph SVP and General Counsel | Option exercise · Stock Option (Right to Buy) | −13,000 | 12,000 | ||
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Option exercise | +7,000 | $91.79 | $643K | 7,000 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −500 | $267.88 | $134K | 6,500 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −300 | $268.99 | $81K | 6,200 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −700 | $270.25 | $189K | 5,500 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −800 | $271.27 | $217K | 4,700 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −1,500 | $272.74 | $409K | 3,200 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −539 | $273.48 | $147K | 2,661 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −400 | $274.70 | $110K | 2,261 |
| 2022-12-23 | Lynch Brian Joseph SVP and General Counsel | Sale | −100 | $275.24 | $28K | 2,161 |
Page 49 of 82 · 1,629 trades